Cargando…
Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease
Measurement of a single marker of coagulation may not provide a complete picture of hemostasis activation and fibrinolysis in patients with chronic cardiovascular diseases. We assessed retrospective orders of a panel which included prothrombin fragment 1.2 (PF1.2), thrombin: antithrombin complexes,...
Autores principales: | Miller, Maureen J., Maier, Cheryl L., Duncan, Alexander, Guarner, Jeannette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274080/ https://www.ncbi.nlm.nih.gov/pubmed/34235983 http://dx.doi.org/10.1177/10760296211032292 |
Ejemplares similares
-
Clinical Evaluation of the Pre-Analytical Capabilities of Hemostasis Instrument
por: Yang, Mingyu, et al.
Publicado: (2022) -
The Association of Coagulation Indicators and Coagulant Agents With 30-Day Mortality of Critical Diabetics
por: Huang, Yingxin, et al.
Publicado: (2021) -
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Myllylahti, Lasse, et al.
Publicado: (2023) -
Validation of an admission coagulation panel for risk stratification of COVID-19 patients
por: Alabyad, Darwish, et al.
Publicado: (2021) -
Assessment of functionalities and attitude toward telemedicine for
patients with cardiovascular disease
por: Knaepen, Lieselotte, et al.
Publicado: (2023)